2 Kormányhivatalnok megvesztegetése 2 Kereskedelmi vesztegetés 3 Ügymenetkönnyítő kifizetések és visszafizetések 3 Együttműködés megbízottakkal és más harmadik felekkel 3 Átvilágítási és jóváhagyási eljárás 3 Figyelmeztető jelzések 4 Számviteli és nyilvántartás-vezetési követelmények 4 Az irányelv lehetséges megsértéseinek jelentése 4 Avient etikai forródrót 5 Megtorlással szembeni védelem 5 Gyors hivatkozás: HELYES ÉS HELYTELEN ELJÁRÁSOK AZ ABAC SZERINT 6 1 Globális vesztegetésellenes és korrupcióellenes irányelvünk Az Avient minden üzleti műveletével kapcsolatban szigorúan tiltja a csalást, a vesztegetést és az egyéb korrupt üzleti gyakorlatokat a világ minden részén. subject= 4 A kockázat minimálisra csökkentése érdekében az Avientnek figyelembe kell vennie bizonyos tényezőket, mielőtt üzleti kapcsolatba lépne bármely harmadik féllel, és minden harmadik fél köteles megfelelni a következő követelményeknek: • ó hírnév - kellő tapasztalattal és szakértelemmel bír • Hiteles - az üzleti referenciák alátámasztják a harmadik fél szakértelmére vonatkozó állításait • Pénzügyileg stabil - megfelelő erőforrások kötelezettségek teljesítésére • Etikai és jogi gyakorlatok - elkötelezett az alkalmazandó jogszabályok betartása mellett, beleértve a megvesztegetés elleni jogszabályokat is; és • Elkötelezett - aláírja a jelen irányelv tudomásul vételét és az annak betartására vonatkozó szerződést.

2 Praktik Suap terhadap Pejabat Pemerintah 2 Praktik Suap Komersial 3 Pembayaran Uang Pelicin dan Balas Jasa 3 Bekerja Sama dengan Agen, Distributor, dan Pihak Ketiga Lainnya 3 Uji Tuntas dan Proses Persetujuan 3 Tanda Bahaya 4 Persyaratan Akuntansi dan Pencatatan 4 Melaporkan Kemungkinan Pelanggaran 4 Saluran Langsung Etika Avient 5 Perlindungan dari Pembalasan Dendam 5 Referensi Cepat: ANJURAN DAN LARANGAN ABAC 6 1 Kebijakan Global Kita tentang Antisuap dan Antikorupsi Avient melarang keras penipuan, praktik suap, dan praktik bisnis korup lainnya di semua operasi bisnis kita di mana pun di seluruh dunia. subject= 4 mempertimbangkan faktor tertentu sebelum menandatangani hubungan dengan pihak ketiga dan semua pihak ketiga harus memenuhi standar berikut: • Memiliki reputasi baik – memiliki pengalaman dan keahlian yang diperlukan • Kredibel - referensi bisnis mendukung klaim keahlian pihak ketiga • Stabil secara finansial - sumber daya memadai untuk memenuhi komitmen • Praktik etika & hukum - berkomitmen untuk mematuhi semua undang-undang yang berlaku, termasuk undang-undang antisuap; dan • Berkomitmen - menandatangani pernyataan, dan perjanjian untuk mematuhi, Kebijakan ini Tanda Bahaya Avient juga dapat dimintai pertanggungjawaban berdasarkan Undang-undang ABAC atas tindakan agen dan pihak ketiga lainnya (termasuk mitra usaha patungan).

www.fojas.cl Pag: 1/1 Pag: 1/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 2/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 3/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 4/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 5/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 6/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 7/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 8/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 9/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 10/11 Certificado Nº 123456880196 Verifique validez en http://www.fojas.cl Pag: 11/11 2021-05-31T12:52:48-0400 Santiago - Chile EDUARDO JAVIER DIEZ MORELLO Notario Publico Eduardo_Diez_Morello

Garratt — 2,289 (1) 183,137 (1) 366,274 (1) — — — — — — 19,750 (2) 158,000 (2) 316,000 (2) — — — — — 2/22/2024 — — — 6,867 (2) 20,600 (2) — 39.27 254,580 7/22/2024 — — — (4) (4) — 39.27 271,822 7/22/2024 — — — (4) (4) 42.93 73,607 7/22/2024 — — — (4) (4) — 52.64 12,035 2/22/2024 — — — — — 6,400 (6) — 251,328 7/22/2024 — — — — — (7) — 253,779 7/22/2024 — — — — — (7) — 137,257 7/22/2024 — — — — — (7) — 41,150 Estimated Future Payouts Under Non-Equity Incentive Plan Awards (columns (c), (d) and (e)) (1) 2024 Annual Incentive Program Opportunities. Sanders 4/29/2024 — — — — — 20,343 831,215 C.L. Letter to our Shareholders 4.

$0.30 $0.52 2019 PF 2020 Q4 2020 ORGANIC PERFORMANCE 3 Sales $922 $997 2019 PF 2020 +8% Adjusted Operating Income Adjusted EPS $58 $80 2019 PF 2020 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 4 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI 2019PF 2020 +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total 2019 PF 2020 $17 $19 $40 $18 $30 $58 Distribution SEM CAI 2019PF 2020 +38% +45% +58% +6% (3) (3) ($ in millions) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 5 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 6 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. 10 2021 O U TLO O K Synergies ($ millions) Initial Three-Year Estimate Revised Three-Year Estimate 2021 Expected Realization Administrative $ 18 $ 20 $ 15 Sourcing 24 30 15 Operational 18 25 5 Total Synergies $ 60 $ 75 $ 35 CLARIANT INTEGRATION & COST SYNERGIES UPDATE 12 • Integration going extremely well: synergy target increased from $60 million to $75 million • $5 million of synergies in 2020 and expect to realize $35 million in 2021 • Relentless focus on guiding principles of safety first, employee collaboration and exceeding customer expectations • Future revenue synergies are not part of these estimates and represent additional growth over the long term $86 $103 2020PF 2021E $0.53 $0.70 2020PF 2021E ORGANIC GROWTH PROJECTIONS – Q1 (TOTAL COMPANY) 13 Sales Adjusted Operating Income $991 $1,090 2020PF 2021E + 10% Adjusted EPS + 20% + 32% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition $308 $360 2020PF 2021E $1.93 $2.40 2020PF 2021E ORGANIC GROWTH PROJECTIONS – FULL YEAR (TOTAL COMPANY) 14 Sales Adjusted Operating Income $3,783 $4,100 2020PF 2021E + 8% Adjusted EPS + 17% + 24% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) (1) (in millions) (in millions) (1) 2020 Pro forma $3,783 $308 Sustainable Solutions 60 11% 24 Healthcare 60 11% 18 Composites 20 10% 10 Growth in Emerging Regions 50 7% 11 Other (GDP growth) 82 5% 11 Sub-total $4,055 7% $382 COVID Response Applications (25) - (11) Outdoor High Performance Applications (15) - (7) Asia Payroll Tax Subsidy (COVID) - - (4) FX Impact 85 - 7 Synergies - - 30 Incentives, Travel, Other Employee Costs - - (37) 2021 Estimated $4,100 8% $360 2021 ORGANIC SALES AND OPERATING INCOME (TOTAL COMPANY) 15 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) COVID Response Applications: facemasks, personal protective equipment Sales Growth Rate Adjusted Operating Income$ millions (1) (2) CASH FLOW AND LEVERAGE 16 • Asset light business generates significant free cash flow • Cash generation in 2021 partially offset by restructuring activities to capture synergies associated with the Clariant Masterbatch acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition ($ millions) 2020 2021E Adjusted EBITDA 382 510 Working Capital: Source / (Use) 116 (30) Cash Taxes (40) (53) Interest Paid (67) (76) CapEx (62) (75) CapEx for Synergy Capture (2) (20) Restructuring for Synergy Capture (11) (25) Other 22 19 Free Cash Flow 338 250 We sell solutions not commodities. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 22 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 6 2 3 4 4 5 5 5 6 6 6 7 9 25 A vi en t A vi en t (E xc l.

Englewood, Colorado Maryland Heights, Missouri(b) 4. Barcelona, Spain 4. VOCs: 669.99 MT 4.

BLOOD LANCET MANUFACTURER S E A L I N G R I N G • Compliance with strict regulations for medical materials • Excellent sealing performance • Good compression set • Provided a recycled TPE solutions compared to silicone without increasing system cost • Delivered a TPE that complied with ISO 10993-4 & -5 and USP Class VI • Supported a change to an injection molded material to ease production and enhance assembly capabilities Versaflex™ HC TPEs – OM1040-1 Grade KEY REQUIREMENTS WHY AVIENT?

PRE-FILLED SYRINGE COMPANY S Y R I N G E T I P C A P • Excellent sealing performance • No DEHP or natural rubber latex added during processing • Can be sterilized by EtO • Compliant with ISO 10993-4&5 and USP Class VI • Formulated a solution that met rigorous medical application requirements • Leveraged global footprint to ensure supply continuity • Increased process efficiency by replacing previous thermoset material with a TPE Versaflex™ HC Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?

Committees: 1, 4 KIM ANN MINK, Ph.D. Chief Technology Off icer, Colgate-Palmolive Company Committees: 3, 4 WILLIAM A. Environmental, Health and Safety 4.

Englewood, Colorado Maryland Heights, Missouri(b) 4. Barcelona, Spain 4. VOCs: 669.99 MT 4.